Sort   by:  
 Page size 
UnknownPirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study.
Not available
S-EPMC12686794 | biostudies-literature
UnknownEverolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.
Not available
S-EPMC10774869 | biostudies-literature
UnknownPhase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Not available
S-EPMC6340722 | biostudies-literature
UnknownThe DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia.
Not available
S-EPMC6265654 | biostudies-literature
UnknownDual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer.
Not available
S-EPMC4278330 | biostudies-literature
UnknownA phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.
Not available
S-EPMC4297242 | biostudies-literature
UnknownSotorasib for Lung Cancers with KRAS p.G12C Mutation.
Not available
S-EPMC9116274 | biostudies-literature
UnknownThe BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC5065110 | biostudies-literature
UnknownRandomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
Not available
S-EPMC10497190 | biostudies-literature
UnknownBacille Calmette-Guerin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial.
Not available
S-EPMC11106519 | biostudies-literature
Sort   by:  
 Page size